Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: Plipastatin is a potent Bacillus antimicrobial lipopeptide with the prospect to replace conventional antifungal chemicals for controlling plant pathogens. However, the application of this lipopeptide has so far been investigated in a few cases, principally because of the yield in low concentration and unknown regulation of biosynthesis pathways. B. subtilis synthesizes plipastatin by a non-ribosomal peptide synthetase encoded by the ppsABCDE operon. In this study, B. subtilis 3NA (a non-sporulation strain) was engineered to gain more insights about plipastatin mono-production. Results: The 4-phosphopantetheinyl transferase Sfp posttranslationally converts non-ribosomal peptide synthetases from inactive apoforms into their active holoforms. In case of 3NA strain, sfp gene is inactive. Accordingly, the first step was an integration of a repaired sfp version in 3NA to construct strain BMV9. Subsequently, plipastatin production was doubled after integration of a fully expressed degQ version from B. subtilis DSM10 T strain (strain BMV10), ensuring stimulation of DegU-P regulatory pathway that positively controls the ppsABSDE operon. Moreover, markerless substitution of the comparably weak native plipastatin promoter (P pps ) against the strong constitutive promoter P veg led to approximately fivefold enhancement of plipastatin production in BMV11 compared to BMV9. Intriguingly, combination of both repaired degQ expression and promoter exchange (P pps ::P veg ) did not increase the plipastatin yield. Afterwards, deletion of surfactin ( srfAA-AD ) operon by the retaining the regulatory comS which is located within srfAB and is involved in natural competence development, resulted in the loss of plipastatin production in BMV9 and significantly decreased the plipastatin production of BMV11. We also observed that supplementation of ornithine as a precursor for plipastatin formation caused higher production of plipastatin in mono-producer strains, albeit with a modified pattern of plipastatin composition. Conclusions: This study provides evidence that degQ stimulates the native plipastatin production. Moreover, a full plipastatin production requires surfactin synthetase or some of its components. Furthermore, as another conclusion of this study, results point towards ornithine provision being an indispensable constituent for a plipastatin mono-producer B. subtilis strain. Therefore, targeting the ornithine metabolic flux might be a promising strategy to further investigate and enhance plipastatin production by B. subtilis plipastatin mono-producer strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3 A Detected HPTLC chromatograms of the standard plipastatin in comparison with plipastatin produced by BMV9 (3NA sfp +) and BMV12 (3NA plipastatin mono-producer) with and without ornithine supplementation. Plipastatin standard produced by B. subtilis (Lipofabrik, France) [a], plipastatin produced by BMV9 strain after 48 h cultivation in mineral salt medium without any amino acid and with ornithine supplementation [b]; plipastatin produced by BMV12 strain after 48 h cultivation in mineral salt medium without amino acid and with ornithine supplementation [c]. B Comparison of plipastatin variants ratios in plipastatin standard and mono-producer BMV12 strain during exponential and stationary phase. The BMV12 was cultivated in mineral salt medium supplemented with 30 mM of ornithine. The samples were taken after 24 h (exponential phase) and 48 h (stationary phase). Peak areas were determined by extracted ion chromatograms for each plipastatin variant using their precise m/z values. Ratios of the peak areas of plipastatin variants were calculated within the standard and the two sample points](https://figures.cochat.ai/paper-figures/db7fce5b4aa64af2ab468566329155d5/construction-and-description-of-a-constitutive-plipastatin-mono-producing-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“B. subtilis BMV9 was used as a promising surfactin production strain [10].”
From The influence of growth rate-controlling feeding strategy on the surfactin production in Bacillus subtilis bioreactor processes (2024) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yanisch-Perron, C., Vieira, J., & Messing, J. (1985) · Gene · doi:10.1016/0378-1119(85)90120-9 · Cited by 15,041
The complete genome sequence of the gram-positive bacterium Bacillus subtilis.
Kunst, F., Ogasawara, N., Moszer, I., Albertini, A. M., Alloni, G., Azevedo, V., Bertero, M. G., Bessières, P., Bolotin, A., Borchert, S., et al. (1997) · Nature · doi:10.1038/36786 · Cited by 3,679
Applied Microbiology and Biotechnology
(2013) · Applied Microbiology and Biotechnology · doi:10.1007/253.1432-0614 · Cited by 3,515
Antimicrobial agents and chemotherapy—1969
Parker, R. H. (1971) · Journal of Chronic Diseases · doi:10.1016/0021-9681(71)90113-5 · Cited by 2,504
Chung, C. T., Niemela, S. L., & Miller, R. H. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2172 · Cited by 1,592
Smith, M. C. M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80059-c · Cited by 1,519
Journal of Microbiology and Biotechnology
(2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb · Cited by 1,466
Molecular biological methods for Bacillus
Harwood, C. R., & Cutting, S. M. (1990) · Cited by 1,430
Raaijmakers, J. M., De Bruijn, I., Nybroe, O., & Ongena, M. (2010) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00221.x · Cited by 1,131
Ongena, M., Jourdan, E., Adam, A., Paquot, M., Brans, A., Joris, B., Arpigny, J., & Thonart, P. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2006.01202.x · Cited by 855
Cited by
Wolf, S., Becker, J., Tsuge, Y., Kawaguchi, H., Kondo, A., Marienhagen, J., Bott, M. H., Wendisch, V. F., & Wittmann, C. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200134 · Cited by 139
Put, H., Gerstmans, H., Capelle, H. V., Fauvart, M., Michiels, J. J., & Masschelein, J. (2024) · Natural Product Reports · doi:10.1039/d3np00065f · Cited by 85
Antimicrobial peptides from Bacillus spp. and strategies to enhance their yield
Puan, S. L., Erriah, P., Baharudin, M. M. A.-A., Normi, Y. M., Kamil, W. N. I. W. A., Ali, M. S. M., Ahmad, S. A., Oslan, S. N., Lim, S., & Sabri, S. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12651-9 · Cited by 75
Bacillus lipopeptides as key players in rhizosphere chemical ecology
Balleux, G., Höfte, M., Arias, A. A., Deleu, M., & Ongena, M. (2024) · Trends in Microbiology · doi:10.1016/j.tim.2024.08.001 · Cited by 74
Vahidinasab, M., Adiek, I., Hosseini, B., Akintayo, S. O., Abrishamchi, B., Pfannstiel, J., Henkel, M., Lilge, L., Voegele, R. T., & Hausmann, R. (2022) · Microorganisms · doi:10.3390/microorganisms10112225 · Cited by 72
Self-citation
Metadata
- Authors
- Vahidinasab, M., Lilge, L., Reinfurt, A., Pfannstiel, J., Henkel, M., Morabbi Heravi, K., & Hausmann, R.
- Affiliations
- University of Hohenheim (DE)
- Corresponding author
- Lilge, Lars
- Venue
- Microbial Cell Factories
- Published
- 2020-11-10
- Volume
- 19
- Issue
- 1
- Pages
- 205-205
- ISSN
- 1475-2859 (ISSN-L)
- PMC
- PMC7654001
- OpenAlex
- W3102096247
- Cited by
- 68
- References
- 67
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 22 · 2023: 8 · 2022: 10 · 2021: 7
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Microbial Cell Factories (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Food Security Center at the University of Hohenheim (57160040)
- Projekt DEAL
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- plipastatin, Bacillus subtilis, nonribosomal peptide synthetase, DegQ, surfactin, COMS, biosynthetic regulation, antifungal lipopeptides, plant disease control
- MeSH terms
- Anti-Infective Agents, Bacillus subtilis, Bacterial Proteins, Fatty Acids, Oligopeptides, Operon, Peptide Synthases, Peptides, Cyclic, Promoter Regions, Genetic, Lipopeptides, Metabolic Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis. https://app.cochat.ai/papers/10.1186/s12934-020-01468-0
- The paper
- Vahidinasab, M., Lilge, L., Reinfurt, A., Pfannstiel, J., Henkel, M., Morabbi Heravi, K., & Hausmann, R. (2020). Construction and description of a constitutive plipastatin mono-producing Bacillus subtilis. Microbial Cell Factories. https://doi.org/10.1186/s12934-020-01468-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.